Skip to main content

UBS Group AG

Position in EVO — Evotec SE

CIK 1610520 ZURICH, V8

Position in EVO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,752
-$31,684 QoQ
Shares Held
1,501
-84.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in EVO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,752 1,501
2025-09-30 $35,436 9,762
2025-06-30 $43,511 10,360
2025-03-31 $45,490 13,620
2024-12-31 $15,416 3,706
2024-09-30 $3,759 1,030
2024-06-30 $4,944 1,030
2024-03-31 $13,827 1,766
2023-12-31 $26,674 2,274
2023-09-30 $18,150 1,839
2023-06-30 $82,772 7,325
2023-03-31 $13,898 1,330
2022-12-31 $26,987 3,336
2022-09-30 $25,367 2,886
2022-06-30 $3,594 300
2022-03-31 $26,583 1,757
2021-12-31 $47,286 1,991